The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray

Journal of Immunology - Tập 197 Số 10 - Trang 3755-3761 - 2016
J. J. Clariá1,2, Vicente Arroyo3, Richard Moreau4
1*Servei de Bioquímica i Genètica Molecular, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona 08036, Spain;
2†Department of Biomedical Sciences, University of Barcelona, Barcelona 08036, Spain;
3‡European Foundation for the Study of Chronic Liver Failure, Barcelona 08021, Spain; and
4§INSERM, Université Paris Diderot, Centre de Recherche sur l’Inflammation, Paris 75018, France

Tóm tắt

Abstract

The acute-on-chronic liver failure (ACLF) syndrome is characterized by acute decompensation of cirrhosis, organ failure, and high 28-d mortality. ACLF displays key features of systemic inflammation and its poor outcome is closely associated with exacerbated systemic inflammatory responses. In this review, we describe the prevailing characteristics of systemic inflammation in patients with decompensated cirrhosis and ACLF, with special emphasis on the principal features of the cytokine storm the mechanisms underlying this intense systemic inflammatory response (i.e., presence of circulating pathogen- and damage-associated molecular patterns), and their implication in tissue and organ damage in this condition.

Từ khóa


Tài liệu tham khảo

Arroyo, 2016, Acute-on-chronic liver failure in cirrhosis., Nat. Rev. Dis. Primers, 2, 16041, 10.1038/nrdp.2016.41

Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis., Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042

Gustot, 2015, Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis., Hepatology, 62, 243, 10.1002/hep.27849

Jalan, 2014, Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure., J. Hepatol., 61, 1038, 10.1016/j.jhep.2014.06.012

Bernardi, 2015, Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis., J. Hepatol., 63, 1272, 10.1016/j.jhep.2015.07.004

Barton, 2008, A calculated response: control of inflammation by the innate immune system., J. Clin. Invest., 118, 413, 10.1172/JCI34431

Li, 2007, cDNA microarray analysis reveals fundamental differences in the expression profiles of primary human monocytes, monocyte-derived macrophages, and alveolar macrophages., J. Leukoc. Biol., 81, 328, 10.1189/jlb.0206124

Sica, 2012, Macrophage plasticity and polarization: in vivo veritas., J. Clin. Invest., 122, 787, 10.1172/JCI59643

Ziegler-Heitbrock, 2010, Nomenclature of monocytes and dendritic cells in blood., Blood, 116, e74, 10.1182/blood-2010-02-258558

Gebreselassie, 2012, Eosinophils preserve parasitic nematode larvae by regulating local immunity., J. Immunol., 188, 417, 10.4049/jimmunol.1101980

Clària, 2012, Natural killer cell recognition and killing of activated hepatic stellate cells., Gut, 61, 792, 10.1136/gutjnl-2011-301968

Liu, 2016. Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure., Clin. Res. Hepatol. Gastroenterol

Clark, 2007, The advent of the cytokine storm., Immunol. Cell Biol., 85, 271, 10.1038/sj.icb.7100062

Rittirsch, 2008, Harmful molecular mechanisms in sepsis., Nat. Rev. Immunol., 8, 776, 10.1038/nri2402

Clària, 2016, Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure., Hepatology., 10.1002/hep.28740

Pinsky, 1993, Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality., Chest, 103, 565, 10.1378/chest.103.2.565

Gabay, 1999, Acute-phase proteins and other systemic responses to inflammation., N. Engl. J. Med., 340, 448, 10.1056/NEJM199902113400607

Baggiolini, 2001, Chemokines in pathology and medicine., J. Intern. Med., 250, 91, 10.1046/j.1365-2796.2001.00867.x

Huang, 1996, Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival., J. Hepatol., 24, 377, 10.1016/S0168-8278(96)80156-5

Dominguez, 2009, Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis., Gastroenterology, 136, 1639, 10.1053/j.gastro.2009.01.056

Albillos, 2014, Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance., J. Hepatol., 61, 1385, 10.1016/j.jhep.2014.08.010

Devière, 1990, Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis., Hepatology, 11, 628, 10.1002/hep.1840110416

Gandoura, 2013, Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis., J. Hepatol., 58, 936, 10.1016/j.jhep.2012.12.025

Tazi, 2006, Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M., J. Hepatol., 45, 280, 10.1016/j.jhep.2006.02.013

Bernsmeier, 2015, Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK., Gastroenterology, 148, 603, 10.1053/j.gastro.2014.11.045

O’Brien, 2014, Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2., Nat. Med., 20, 518, 10.1038/nm.3516

Ramírez, 2004, Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites., J. Hepatol., 41, 44, 10.1016/j.jhep.2004.03.011

Wasmuth, 2005, Patients with acute on chronic liver failure display “sepsis-like” immune paralysis., J. Hepatol., 42, 195, 10.1016/j.jhep.2004.10.019

Bendall, 2014, G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent., Cytokine Growth Factor Rev., 25, 355, 10.1016/j.cytogfr.2014.07.011

Rickard, 2014, RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis., Cell, 157, 1175, 10.1016/j.cell.2014.04.019

Croker, 2015, Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis., Curr. Opin. Hematol., 22, 293, 10.1097/MOH.0000000000000148

Dunn, 2001, Annotating genes with potential roles in the immune system: six new members of the IL-1 family., Trends Immunol., 22, 533, 10.1016/S1471-4906(01)02034-8

Dinarello, 2009, Interleukin-1beta and the autoinflammatory diseases., N. Engl. J. Med., 360, 2467, 10.1056/NEJMe0811014

Lamkanfi, 2014, Mechanisms and functions of inflammasomes., Cell, 157, 1013, 10.1016/j.cell.2014.04.007

Liu, 2016, Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores., Nature, 535, 153, 10.1038/nature18629

Rider, 2011, IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation., J. Immunol., 187, 4835, 10.4049/jimmunol.1102048

Dinarello, 1996, Biologic basis for interleukin-1 in disease., Blood, 87, 2095, 10.1182/blood.V87.6.2095.bloodjournal8762095

Alcaraz-Quiles, 2015, Polymorphisms in the interleukin (IL)-1 gene cluster are associated with multiple markers of systemic inflammation in patients with acute-on-chronic liver failure (ACLF)., Hepatology, 62, 1226A

Fisher, 1994, Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group., JAMA, 271, 1836, 10.1001/jama.1994.03510470040032

Rajasekaran, 2014, Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children., Pediatr. Crit. Care Med., 15, 401, 10.1097/PCC.0000000000000078

Bianchi, 2007, DAMPs, PAMPs and alarmins: all we need to know about danger., J. Leukoc. Biol., 81, 1, 10.1189/jlb.0306164

Takeuchi, 2010, Pattern recognition receptors and inflammation., Cell, 140, 805, 10.1016/j.cell.2010.01.022

Wiest, 2014, Pathological bacterial translocation in liver cirrhosis., J. Hepatol., 60, 197, 10.1016/j.jhep.2013.07.044

Chen, 2015, Dysbiosis-induced intestinal inflammation activates TNFRI and mediates alcoholic liver disease in mice., Hepatology, 61, 883, 10.1002/hep.27489

Rook, 2005, Microbes, immunoregulation, and the gut., Gut, 54, 317, 10.1136/gut.2004.053785

Guerville, 2016, Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation., Am. J. Physiol. Gastrointest. Liver Physiol., 311, G1, 10.1152/ajpgi.00098.2016

Heller, 2000, Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis., J. Hepatol., 33, 376, 10.1016/S0168-8278(00)80272-X

Jirillo, 2002, The role of the liver in the response to LPS: experimental and clinical findings., J. Endotoxin Res., 8, 319

Lucey, 2009, Alcoholic hepatitis., N. Engl. J. Med., 360, 2758, 10.1056/NEJMra0805786

Grønbæk, 2016, Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)., J. Hepatol., 64, 813, 10.1016/j.jhep.2015.11.021

Tsung, 2014, High-mobility group box-1 in sterile inflammation., J. Intern. Med., 276, 425, 10.1111/joim.12276

Medzhitov, 2012, Disease tolerance as a defense strategy., Science, 335, 936, 10.1126/science.1214935

Kono, 2008, How dying cells alert the immune system to danger., Nat. Rev. Immunol., 8, 279, 10.1038/nri2215

Wang, 1999, HMG-1 as a late mediator of endotoxin lethality in mice., Science, 285, 248, 10.1126/science.285.5425.248

Cohen, 2002, The immunopathogenesis of sepsis., Nature, 420, 885, 10.1038/nature01326

Abraham, 2007, Mechanisms of sepsis-induced organ dysfunction., Crit. Care Med., 35, 2408, 10.1097/01.CCM.0000282072.56245.91

Gustot, 2011, Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response., Curr. Opin. Crit. Care, 17, 153, 10.1097/MCC.0b013e328344b446

Iwasaki, 2015, Control of adaptive immunity by the innate immune system., Nat. Immunol., 16, 343, 10.1038/ni.3123

Bortoluzzi, 2013, Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms., Hepatology, 57, 266, 10.1002/hep.26021

Rodríguez-Roisin, 2008, Hepatopulmonary syndrome--a liver-induced lung vascular disorder., N. Engl. J. Med., 358, 2378, 10.1056/NEJMra0707185

Gustot, 2009, Severe sepsis in cirrhosis., Hepatology, 50, 2022, 10.1002/hep.23264

Chaisson, 2002, Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy., J. Clin. Invest., 110, 193, 10.1172/JCI0215295

Tazi, 2007, In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats., J. Hepatol., 46, 1075, 10.1016/j.jhep.2007.01.034

Alobaidi, 2015, Sepsis-associated acute kidney injury., Semin. Nephrol., 35, 2, 10.1016/j.semnephrol.2015.01.002

Parikh, 2015, Mitochondrial function and disturbances in the septic kidney., Semin. Nephrol., 35, 108, 10.1016/j.semnephrol.2015.01.011

Plessier, 2003, Coagulation disorders in patients with cirrhosis and severe sepsis., Liver Int., 23, 440, 10.1111/j.1478-3231.2003.00870.x

Chovatiya, 2014, Stress, inflammation, and defense of homeostasis., Mol. Cell, 54, 281, 10.1016/j.molcel.2014.03.030